This is a less common condition, often seen in children. It involves a high fever, a rash, joint pain, and a high white blood cell count. It might be related to an allergic reaction or a severe infection.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Wissler's syndrome, also called Wissler-Fanconi syndrome or subsepsis allergica, is an older name for an inflammatory illness marked by high, spiking fevers that last for weeks, joint pain or arthritis, and very high levels of inflammation in blood tests, with no infection to explain them. The fever often rises once or twice a day and then falls back to normal, which is why early doctors compared it to a hidden blood infection (sepsis). Some people also have a faint, salmon-pink rash that comes and goes with the fever, although recent reports use the name for cases where that rash is missing. Today, doctors understand this illness as part of Still's disease. Still's disease was once split by age into systemic juvenile idiopathic arthritis in children and adult-onset Still's disease in adults; international experts now treat them as a single disease. It is rare, and because it looks so much like a serious infection, people are often investigated for weeks before the diagnosis is made.
The original name reflected a belief that the illness was an allergic reaction. That idea has not held up. Still's disease is now considered autoinflammatory, meaning the body's built-in first-line defenses switch on and drive inflammation without a clear outside cause. Researchers do not yet know why this happens in a particular person. The disease can start at almost any age. It is most common in young children, and in adults it tends to begin in the late teens to mid-20s or in the late 30s to mid-40s, with women affected slightly more often. Infections do not cause Still's disease, but they can set off a flare or a serious complication in someone who already has it.
No single test confirms the diagnosis. A doctor pieces it together from the pattern of symptoms and blood results, and only after ruling out the illnesses it can imitate: infections, cancers (especially lymphoma, a cancer of the immune system) and other inflammatory or rheumatic diseases. This step matters because the steroids and immune-calming medicines used for Still's disease could be harmful if the real cause were an infection or cancer. The typical picture is a spiking fever of 39°C (102.2°F) or higher for at least a week, joint pain lasting two weeks or more, and blood tests showing a high white blood cell count made up mostly of neutrophils (infection-fighting cells), raised inflammation markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), and often abnormal liver tests. Tests for antibodies seen in lupus and rheumatoid arthritis are usually negative. A very high ferritin, a protein that normally stores iron but also rises sharply with inflammation, is an important clue: a level more than five times the upper limit of normal strongly suggests Still's disease when the rest of the picture fits. Evaluation usually includes blood cultures and other infection tests, imaging, and sometimes a bone marrow test to look for blood cancers. Doctors often check the result against a published checklist of findings (the Yamaguchi criteria), which helps but does not replace clinical judgment.
Treatment aims to stop the fever and inflammation quickly, protect the joints, prevent serious complications and, eventually, keep the disease quiet with as little medicine as possible. Current European guidance for children and adults favors starting a biologic medicine that blocks interleukin-1 (IL-1) or interleukin-6 (IL-6), two immune signaling proteins that drive the fever and inflammation, as soon as the diagnosis is established. Examples include canakinumab (Ilaris), which is approved in the US for Still's disease in people 2 and older; tocilizumab (Actemra), approved in the US for the childhood form; and anakinra (Kineret), a short-acting IL-1 blocker widely used for Still's disease although it is not specifically approved for it in the US. These medicines are given by injection or infusion and often bring rapid improvement. Steroids such as prednisone work quickly and are used at high doses when the illness is severe, but long-term use causes serious side effects, so the plan is to reduce them and stop within a few months where possible. Methotrexate, an older immune-modifying medicine, is sometimes added, mainly for persistent joint problems or where biologics are not available. Anti-inflammatory pain relievers (NSAIDs) such as ibuprofen can ease fever and joint pain in mild cases or while tests are under way, but they rarely control the disease on their own. The main trade-off with IL-1 and IL-6 blockers is a higher risk of serious infections. Because these medicines can also mask fever and lower inflammation markers, an infection may be less obvious than usual, so new symptoms deserve attention even without a high temperature. People who do not respond well, or who develop serious complications, are best cared for with input from a specialist center.
The course varies a great deal. Some people have a single episode that settles completely over weeks to months. Others have repeated flares separated by long, symptom-free periods. The most common pattern is a longer-lasting form in which joint inflammation persists, and over years it can damage joints if it is not well controlled. With early treatment, many people reach a point where they have no symptoms and normal inflammation tests, and a substantial number can eventually stop medicine altogether. Getting there usually means regular visits with a rheumatologist and frequent blood tests at first, then a gradual step-down of steroids and later of the biologic, often by spacing out injections. During active illness, fatigue, fever and joint pain can interrupt work or school; once the disease is controlled, daily life is often close to normal, but ongoing monitoring continues because flares can return.
See a doctor if you or your child has a high fever lasting more than a week with joint pain or a passing rash and no clear infection, especially if blood tests already show high inflammation. Asking for a rheumatology opinion can shorten a long search for the cause. If you have already been diagnosed, contact your treating team promptly if the fever returns, joints flare, or you feel suddenly much more unwell, or develop a new cough, shortness of breath, chest pain or yellowing of the skin. These can signal a relapse or a complication called macrophage activation syndrome (MAS), a dangerous surge of inflammation that can appear at any stage, even when the disease seemed controlled, and needs rapid treatment. While taking IL-1 or IL-6 blockers, report signs of infection the same day, even without a high temperature. Severe difficulty breathing or chest pain with fainting needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Wissler's Syndrome is like, what's helped you, or ask the community a question.